惠泰医疗收盘上涨1.31%，滚动市盈率63.21倍，总市值425.70亿元

Group 1 - The core viewpoint of the article highlights the performance and market position of Huatai Medical, which closed at 438.5 yuan with a PE ratio of 63.21 times, significantly higher than the industry average of 47.69 times [1] - Huatai Medical's total market capitalization is 42.57 billion yuan, ranking 97th in the medical device industry based on PE ratio [1] - As of the third quarter of 2024, 40 institutions hold shares in Huatai Medical, with a total of 4.71 million shares valued at 1.825 billion yuan [1] Group 2 - Huatai Medical specializes in the research, production, and sales of cardiovascular interventional medical devices, with key products including electrophysiology, coronary access, peripheral vascular interventional, and non-vascular interventional medical devices [1] - The company has established itself as a leader in the domestic electrophysiology market, being the first domestic manufacturer to receive approval for its electrophysiological electrode catheters and radiofrequency ablation electrode catheters [1] - The latest financial results for the third quarter of 2024 show that Huatai Medical achieved an operating income of 1.525 billion yuan, a year-on-year increase of 25.63%, and a net profit of 528 million yuan, up 30.97%, with a gross profit margin of 72.69% [1]